⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX DEADLINE: MoonLake Immunotherapeutics Investors are Encouraged to Act before the Upcoming December 15 Deadline - Contact BFA Law if You Lost Money
accessnewswire.com
MLTX
TSLA
MoonLake Immunotherapeutics (MLTX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Issues Important Reminder to Investors in MoonLake Immunotherapeutics of Class Action Filing – MLTX
accessnewswire.com
MLTX
MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors - Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
Levi & Korsinsky Moves to SueWallSt For MoonLake Immunotherapeutics Investors That Lost Money
accessnewswire.com
MLTX
MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman
prnewswire.com
MLTX
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – MLTX
globenewswire.com
MLTX
MLTX Class Action Reminder – Robbins LLP Reminds MoonLake Immunotherapeutics Stockholders of the Opportunity to Lead the Class Action Lawsuit
globenewswire.com
MLTX
MOONLAKE NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations after Stock Drops 90%, Investors Urged to Contact BFA Law
newsfilecorp.com
MLTX